Cargando…
Sarcoidosis-like reaction induced by immune checkpoint inhibitor in a patient with hepatocellular carcinoma: a case report
Nowadays, immune checkpoint inhibitors (ICI) have become the cornerstone of treatment for many tumors, either as monotherapy or in combination with other therapies. However, these drugs are associated with several new side effects that need early detection. We present the case of a 41-year-old male...
Autores principales: | Torres-Zurita, Alberto, Vázquez-Montero, Lucía, Gallego-López, Laura, Mediano-Rambla, María Dolores, de la Cruz-Merino, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533992/ https://www.ncbi.nlm.nih.gov/pubmed/37781378 http://dx.doi.org/10.3389/fimmu.2023.1150128 |
Ejemplares similares
-
Hilar/mediastinal and cutaneous drug-induced sarcoidosis-like reaction associated with immune checkpoint inhibitors in metastatic colorectal cancer: a case report
por: Sagawa, Tamotsu, et al.
Publicado: (2023) -
A case of sarcoidosis‐like reaction associated with immune checkpoint inhibitors in metastatic renal cell carcinoma
por: Katagiri, Akiyoshi, et al.
Publicado: (2021) -
Immune Checkpoint Inhibitor–Associated Sarcoidosis Reaction in the Kidney: Case Report
por: Charkviani, Mariam, et al.
Publicado: (2023) -
Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma
por: Chen, Yue, et al.
Publicado: (2022) -
Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma
por: Mohr, Raphael, et al.
Publicado: (2021)